Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
Meta Platforms (Facebook)
META
|
+$446M |
| 3 |
Johnson & Johnson
JNJ
|
+$306M |
| 4 |
Evergy
EVRG
|
+$288M |
| 5 |
Walmart Inc
WMT
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$596M |
| 2 |
Booking.com
BKNG
|
+$519M |
| 3 |
Amazon
AMZN
|
+$518M |
| 4 |
Eli Lilly
LLY
|
+$268M |
| 5 |
UnitedHealth
UNH
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.51% |
| 2 | Technology | 14.39% |
| 3 | Financials | 11.76% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Real Estate | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Aspen Aerogels
ASPN
$504M
| $2.37M | ﹤0.01% |
483,800
+54,100
| +13% | +$257K |
|
2177
SiriusPoint
SPNT
$2.7B
| $2.37M | ﹤0.01% |
189,567
+133,367
| +237% | +$1.78M |
|
|
SCX
2178
DELISTED
The L.S. Starrett Company
SCX
| $2.37M | ﹤0.01% |
370,190
+12,690
| +4% | +$83.2K |
|
|
QIWI
2179
DELISTED
QIWI PLC
QIWI
| $2.37M | ﹤0.01% |
150,300
+18,847
| +14% | +$323K |
|
|
ARR
2180
Armour Residential REIT
ARR
$2.37B
| $2.36M | ﹤0.01% |
20,704
+14,285
| +223% | +$1.64M |
|
2181
BioLife Solutions
BLFS
$1.72B
| $2.36M | ﹤0.01% |
206,900
+179,100
| +644% | +$1.63M |
|
2182
Lifetime Brands
LCUT
$220M
| $2.36M | ﹤0.01% |
186,300
-4,900
| -3% | -$57.3K |
|
2183
Weyco Group
WEYS
$437M
| $2.35M | ﹤0.01% |
64,699
+14,999
| +30% | +$532K |
|
|
GMLP
2184
DELISTED
Golar LNG Partners LP
GMLP
| $2.35M | ﹤0.01% |
152,100
-128,100
| -46% | -$2.32M |
|
|
AGTC
2185
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.35M | ﹤0.01% |
634,500
+140,700
| +28% | +$651K |
|
|
GURE
2186
Gulf Resources
GURE
$5.48M
| $2.35M | ﹤0.01% |
33,982
+306
| +0.9% | +$21.7K |
|
2187
Karyopharm Therapeutics
KPTI
$45.1M
| $2.34M | ﹤0.01% |
+9,193
| New | +$2.27M |
|
2188
EyePoint Inc
EYPT
$1.16B
| $2.34M | ﹤0.01% |
112,430
-29,880
| -21% | -$586K |
|
|
MTLS
2189
Materialise
MTLS
$397M
| $2.33M | ﹤0.01% |
179,600
+57,300
| +47% | +$702K |
|
|
NTUS
2190
DELISTED
Natus Medical Inc
NTUS
| $2.32M | ﹤0.01% |
67,345
-98,600
| -59% | -$3.46M |
|
|
PTX
2191
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $2.32M | ﹤0.01% |
953,750
+12,500
| +1% | +$30.6K |
|
|
HIFR
2192
DELISTED
InfraREIT, Inc.
HIFR
| $2.32M | ﹤0.01% |
104,500
+21,300
| +26% | +$447K |
|
2193
Fresenius Medical Care
FMS
$12.6B
| $2.32M | ﹤0.01% |
46,000
-4,300
| -9% | -$218K |
|
2194
Harte-Hanks
HHS
$20.8M
| $2.31M | ﹤0.01% |
208,472
+23,232
| +13% | +$238K |
|
2195
Cumberland Pharmaceuticals
CPIX
$118M
| $2.31M | ﹤0.01% |
377,209
+23,709
| +7% | +$148K |
|
2196
Lexicon Pharmaceuticals
LXRX
$1.04B
| $2.31M | ﹤0.01% |
192,426
-36,660
| -16% | -$375K |
|
2197
BK Technologies
BKTI
$286M
| $2.3M | ﹤0.01% |
124,400
+500
| +0.4% | +$9.43K |
|
|
NVCN
2198
DELISTED
Neovasc Inc.
NVCN
| $2.3M | ﹤0.01% |
2,150
+1,921
| +839% | +$1.99M |
|
|
KREF
2199
KKR Real Estate Finance Trust
KREF
$502M
| $2.29M | ﹤0.01% |
+115,938
| New | +$2.33M |
|
|
CORV
2200
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $2.29M | ﹤0.01% |
605,423
+76,510
| +14% | +$200K |
|
Similar funds
Jim Simons's Q2 2018 Portfolio in Review
As of Q2 2018, Jim Simons held 3,750 positions worth $91.7B, up 0.34% from $91.4B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons withdrew a net $3.9B in Q2 2018, closing 524 positions and reducing 1,111 holdings. Its most notable exit was Booking.com, an estimated $519M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
Against the trend, Jim Simons opened a new position in Apple worth $707M.
- Jim Simons's largest Q2 2018 buy was Apple: 15,275,332 shares worth $707M.
- Jim Simons added most to Johnson & Johnson in Q2 2018, an estimated $306M increase.
- Jim Simons's biggest Q2 2018 reduction was Home Depot, cutting an estimated $596M.
- Jim Simons fully exited Booking.com in Q2 2018, selling an estimated $519M.
- Jim Simons's ten largest holdings make up 9.1% of its $91.7B portfolio in Q2 2018.
- Jim Simons opened 412 new positions and closed 524 in Q2 2018.
- Jim Simons's portfolio value rose 0.34% quarter-over-quarter to $91.7B.
Based on Renaissance Technologies's 13F filing for Q2 2018, filed 13 Aug 2018.